跳至主要内容
临床试验/JPRN-UMIN000010590
JPRN-UMIN000010590已完成未知

Consideration of combination therapy with both vorinostat and ultraviolet therapy for cutaneous T-cell lymphoma patients - Consideration of combination therapy with both vorinostat and ultraviolet therapy for cutaneous T-cell lymphoma patients

Department of Dermatology, Okayama University0 个研究点目标入组 3 人开始时间: 2013年4月24日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
3

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Patients who have treated with vorinostat 2)During treatment with systemic steroid 3)During treatment with retinoids 4)Carrier of HBV, HCV, HIV and so on 5)Patients who have severe comorbidity 6)During treatment with anti-cancer agents 7)Female who are pregnant or nursing, male hope to impregnate 8)Patients who have past history of severe allergy for vorinostat 9)Patients who are judged inappropriate to be enrolled in this study by the doctor in charge.

研究者

发起方
Department of Dermatology, Okayama University

相似试验